As of May 30, 2026, the three largest insider holders of BCAX are Kiran Mazumdar-Shaw (Director, 6.28Mn shares), Ltd Biocon (TenPercentOwner, 5.52Mn shares), Capital Management, L.P. Ra (Director, 4.60Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Llc Fmr | - | 0 | 1,115,333 | 18 Sep, 2024 |
| Ltd Fil | - | 0 | 1,013,853 | 18 Sep, 2024 |
| Capital Management, L.P. Ra | - | 0 | 4,603,418 | 02 Mar, 2026 |
| James E Flynn | - | 0 | 1,795,174 | 17 Sep, 2024 |
| Gp A, Llc Tpg | - | 0 | 1,960,425 | 18 Sep, 2024 |
| Ryan Cohlhepp | President And Coo | 196,141 | 0 | 17 Apr, 2026 |
| Ivan Hyep | Chief Financial Officer | 145,355 | 0 | 22 Apr, 2026 |
| Claire Mazumdar | Chief Executive Officer | 362,152 | 0 | 20 Apr, 2026 |
| Kiran Mazumdar-Shaw | - | 0 | 6,281,185 | 16 Sep, 2024 |
| David Raben | Chief Medical Officer | 55,286 | 0 | 26 Mar, 2026 |
| Ltd Biocon | - | 0 | 5,523,897 | 16 Sep, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 21 Apr, 2026 | Ivan Hyep | Common Stock | A | 9,200 | $3.79 | 154,555 | D | M |
| 21 Apr, 2026 | Ivan Hyep | Common Stock | D | 9,200 | $23.00 | 145,355 | D | S |
| 21 Apr, 2026 | Ivan Hyep | Stock Option (Right to Buy) | D | 9,200 | $0.00 | 39,744 | D | M |
| 16 Apr, 2026 | Claire Mazumdar | Common Stock | A | 8,226 | $4.44 | 347,618 | D | M |
| 16 Apr, 2026 | Claire Mazumdar | Common Stock | A | 7,454 | $3.79 | 355,072 | D | M |
| 16 Apr, 2026 | Claire Mazumdar | Common Stock | A | 7,080 | $5.45 | 362,152 | D | M |
| 20 Apr, 2026 | Claire Mazumdar | Common Stock | A | 15,000 | $3.79 | 377,152 | D | M |
| 20 Apr, 2026 | Claire Mazumdar | Common Stock | D | 15,000 | $23.61 | 362,152 | D | S |
| 16 Apr, 2026 | Claire Mazumdar | Stock Option (Right to Buy) | D | 8,226 | $0.00 | 56,684 | D | M |
| 16 Apr, 2026 | Claire Mazumdar | Stock Option (Right to Buy) | D | 7,454 | $0.00 | 130,546 | D | M |
| 16 Apr, 2026 | Claire Mazumdar | Stock Option (Right to Buy) | D | 7,080 | $0.00 | 558,432 | D | M |
| 20 Apr, 2026 | Claire Mazumdar | Stock Option (Right to Buy) | D | 15,000 | $0.00 | 161,107 | D | M |
| 15 Apr, 2026 | Ryan Cohlhepp | Common Stock | A | 8,000 | $3.79 | 208,641 | D | M |
| 15 Apr, 2026 | Ryan Cohlhepp | Common Stock | A | 8,000 | $3.79 | 208,641 | D | M |
| 15 Apr, 2026 | Ryan Cohlhepp | Common Stock | A | 8,000 | $3.79 | 208,641 | D | M |
| 15 Apr, 2026 | Ryan Cohlhepp | Common Stock | D | 8,000 | $23.01 | 200,641 | D | S |
| 15 Apr, 2026 | Ryan Cohlhepp | Common Stock | D | 8,000 | $23.01 | 200,641 | D | S |
| 15 Apr, 2026 | Ryan Cohlhepp | Common Stock | D | 8,000 | $23.01 | 200,641 | D | S |
| 15 Apr, 2026 | Ryan Cohlhepp | Common Stock | D | 4,500 | $23.01 | 196,141 | D | S |
| 15 Apr, 2026 | Ryan Cohlhepp | Common Stock | D | 4,500 | $23.01 | 196,141 | D | S |